日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

CD5 缺失可增强过继性 T 细胞疗法的抗肿瘤活性

Patel Ruchi P, Ghilardi Guido, Zhang Yunlin, Chiang Yi-Hao, Xie Wei, Guruprasad Puneeth, Kim Ki Hyun, Chun Inkook, Angelos Mathew G, Pajarillo Raymone, Hong Seok Jae, Lee Yong Gu, Shestova Olga, Shaw Carolyn, Cohen Ivan, Gupta Aasha, Vu Trang, Qian Dean, Yang Steven, Nimmagadda Aditya, Snook Adam E, Siciliano Nicholas, Rotolo Antonia, Inamdar Arati, Harris Jaryse, Ugwuanyi Ositadimma, Wang Michael, Carturan Alberto, Paruzzo Luca, Chen Linhui, Ballard Hatcher J, Blanchard Tatiana, Xu Chong, Abdel-Mohsen Mohamed, Gabunia Khatuna, Wysocka Maria, Linette Gerald P, Carreno Beatriz, Barrett David M, Teachey David T, Posey Avery D, Powell Daniel J Jr, Sauter C Tor, Pileri Stefano, Pillai Vinodh, Scholler John, Rook Alain H, Schuster Stephen J, Barta Stefan K, Porazzi Patrizia, Ruella Marco

Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell Malignancies

嵌合抗原受体T细胞免疫疗法治疗T细胞恶性肿瘤的进展与挑战

Angelos, Mathew G; Patel, Ruchi P; Ruella, Marco; Barta, Stefan K